Scope, modalities, format and organization of the third high-level meeting of the
General Assembly on the prevention and control of non-communicable diseases
A/RES/72/274
Recognizing also that through the adoption of the Addis Ababa Action Agenda
of the Third International Conference on Financing for Development, 3 Heads of State
and Government supported research and development of vaccines and medicines, as
well as preventive measures and treatments for communicable and non-communicable
diseases, in particular those that disproportionately impact developing countries,
Taking note of the report of the Secretary-General on progress on the prevention
and control of non-communicable diseases, 4
Taking note also of the report of the Director General of the World Health
Organization on preparation for the third high-level meeting of the General Assembly
on the prevention and control of non-communicable diseases, to be held in 2018,
Mindful of the need to maintain strong national, regional and international
political commitment towards the prevention and control of non -communicable
diseases,
1.
Decides to hold a one-day high-level meeting to undertake a comprehensive
review of the prevention and control of non-communicable diseases, to be convened
by the President of the General Assembly in New York on the third day of the general
debate of the Assembly at its seventy-third session, from 10 a.m. to 1 p.m. and from
3 to 6 p.m., consisting of an opening segment, a plenary segment for general
discussion, two multi-stakeholder panels and a brief closing segment;
2.
Also decides that the overall theme of the high-level meeting will be
“Scaling up multi-stakeholder and multisectoral responses for the prevention and
control of non-communicable diseases in the context of the 2030 Agenda for
Sustainable Development”;
3.
Further decides that:
(a) The opening segment, to be held from 10 to 11 a.m., will feature statements
by the President of the General Assembly at its seventy-third session, the SecretaryGeneral, the Director General of the World Health Organization, a member of the World
Health Organization Independent High-level Commission on Non-communicable
Diseases, and an eminent champion of the fight against non-communicable diseases,
selected, in consultation with Member States, by the President of the General Assembly,
giving due consideration to gender equity;
(b) The plenary segment, to be held from 11 a.m. to 1 p.m. and 3 to 5:30 p.m.
will comprise statements by Member States and observers of the General Assembly;
a list of speakers will be established in accordance with established practices of the
Assembly and the time limits for these statements will be three min utes for individual
delegations and five minutes for statements made on behalf of a group of States;
4.
Decides that the organizational arrangements for the two multi-stakeholder
panels will be as follows:
(a) Two consecutive multi-stakeholder panels will be held in parallel to the
plenary segment, one from 11 a.m. to 1 p.m. and the other from 3 to 5 p.m.;
(b)
The multi-stakeholder panels will address two themes:
Panel 1: Strengthening health systems and financing for the prevention and
control of non-communicable diseases, on each country’s path towards
achieving universal health coverage, including through sharing evidence -based
best practices, scientific knowledge and lessons learned;
__________________
3
4
2/4
Resolution 69/313, annex.
A Member State expressed a reservation on document A/72/662.
18-05869